Concepedia

Wilson Caulfield

WC

Statistics

Publications

9

Citations

262

H-Index

9

Active since

1999

Affiliations

Discovery Laboratories (United States)(Current)

Merck Serono Ltd. (United Kingdom)

NHS Lanarkshire

Wilson Caulfield is an author at Discovery Laboratories (United States) specializing in medicinal chemistry, drug discovery, and pharmacology.

Publications per year

1999–2011

9

Publications

9

The First Potent and Selective Inhibitors of the Glycine Transporter Type 2

Wilson Caulfield, Iain T. Collie, Rachel S. Dickins et al. · Journal of Medicinal Chemistry · 2001 · 101 citations · Full text

, , +11

Design, synthesis, and structure–activity relationships of indole-3-carboxamides as novel water soluble cannabinoid CB1 receptor agonists

Julia M. Adam, Jim Cairns, Wilson Caulfield et al. · MedChemComm · 2010 · 36 citations

, , +17

Design and optimization of a series of novel 2-cyano-pyrimidines as cathepsin K inhibitors

Zoran Ranković, Jiaqiang Cai, Jennifer Kerr et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 25 citations · Full text

, , +13

Synthesis of novel analogues of the delta opioid ligand SNC-80 using AlCl3-promoted aminolysis

David R. Barn, A. Bom, Jean E. Cottney et al. · Bioorganic & Medicinal Chemistry Letters · 1999 · 22 citations · Full text

, , +13

Parallel synthesis and biological activity of a new class of high affinity and selective δ-opioid ligand

David R. Barn, Wilson Caulfield, Jean E. Cottney et al. · Bioorganic & Medicinal Chemistry · 2001 · 21 citations

, , +17

1–5 of 9